The Effect of Feeding Infant Formula Containing Prebiotics and/or Probiotics
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hainan
-
Haikou, Hainan, China
- Hainan Province Women & Children Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Singleton, 10-14 days of age at registration/randomization
- Term infant with birth weight of 2500 grams or more from a vaginal birth
- Formula feeding infants must be on formula for at least 3 days
- Human milk fed infants must have received mother's own breast milk from 1 day of age to study registration and mother has intention to exclusively provide mother's own breast milk for the duration of the study
- Signed informed consent
Exclusion Criteria:
- History of underlying metabolic or chronic disease or immune compromised
- Feeding difficulties or formula intolerance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Control: Cow milk-based infant formula
Cow milk-based infant formula
|
|
|
Experimental: Experimental 1: Cow milk-based infant formula
Cow milk-based infant formula with prebiotics
|
Experimental 1: Cow milk-based infant formula with prebiotics
|
|
Experimental: Experimental 2: Cow milk-based infant formula
Cow milk-based infant formula with probiotics
|
Experimental 2: Cow milk-based infant formula with probiotics
|
|
Experimental: Experimental 3: Cow milk-based infant formula
Cow milk-based infant formula with prebiotics and probiotics
|
Experimental 3: Cow milk-based infant formula with prebiotics and probiotics
|
|
No Intervention: Human Milk Reference
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in fecal microbiota
Time Frame: 3.5 months
|
3.5 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Head circumference measured at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Recall of gastrointestinal tolerance questionnaire at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Body Weight measured at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Body Length measured at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Recall of infant formula usage at each study visit
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
|
Medically-confirmed adverse events collected throughout the study period
Time Frame: Up to 3.5 months
|
Up to 3.5 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 6026
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.